YahooSeptember 1, 2026 at 10:43 AM NY3 days ago

GSK Stock Down 14% in Six Months: Time to Buy, Hold or Exit?

GSK's shares are down 14% in six months, but strong Specialty Medicines growth and a robust pipeline may support long-term gains.

Read the Full Story at the Source

The summary here comes from the news provider; the rest of the article lives on the publisher's site — Yahoo

Companies in This Story